Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.
Cathie Wood Outlines Role Of Bitcoin Post ETF Approval, Praises 21Shares: ‘The Plumbing Works’
Signs that the U.S. Securities and Exchange Commission (SEC) will approve a Spot Bitcoin exchange-traded fund (ETF) in January are "very encouraging.